|
A systematic review and economic evaluation of pegylated lipsomal doxorubicin hydrochloride for ovarian cancer |
Forbes C, Wilby J, Richardson G, Sculpher M, Mather L, Riemsma R |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Forbes C, Wilby J, Richardson G, Sculpher M, Mather L, Riemsma R. A systematic review and economic evaluation of pegylated lipsomal doxorubicin hydrochloride for ovarian cancer. Health Technology Assessment 2002; 6(23): 1-127 Indexing Status Subject indexing assigned by NLM AccessionNumber 22005008237 Date bibliographic record published 26/04/2005 |
|
|
|